SWOG S1115: Randomized phase II clinical trial of selumetinib (AZD6244; ARRY 142886) hydrogen sulfate (NSC-748727) and MK-2206 (NSC-749607) versus mFOLFOX in patients withmetastatic pancreatic cancer after prior chemotherapy.
Vincent M. Chung
No relevant relationships to disclose
Shannon McDonough
No relevant relationships to disclose
Philip Agop Philip
No relevant relationships to disclose
Dana Backlund Cardin
No relevant relationships to disclose
Andrew M. Lowy
No relevant relationships to disclose
Jacqueline K. Benedetti
No relevant relationships to disclose
Charles Davic Blanke
No relevant relationships to disclose